Clinical Trial Update: Naïve HIV POC Monotherapy Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a treatment-naive HIV POC monotherapy sponsored by Ardea Biosciences has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED